NCT07758660Enrolling by invitationPhase 2
Alzheimer's Disease Research Center (ADRC) PET Component Study
Alzheimer's Disease Research Center PET Component
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years. All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 6 Aug 2026
- Start date
- 6 Aug 2026
- Primary completion date
- 31 May 2031
- Lead sponsor
- Patrick Lao
- Diseases
- Alzheimer disease
- NCT number
- NCT07758660
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 120
- From 6 Aug 2026 to the primary completion date, 31 May 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Conditions precluding entry into the scanners (e.g., morbid obesity, claustrophobia, etc.)
Other
- Pregnant and/or breastfeeding
- In the opinion of the PI, the subject has been determined unlikely to complete all procedures.
Who the study is looking for
- Enrolled in the Alzheimer's Disease Resource Center (ADRC)
- With or without memory problems or impairment
- Able to participate in all scheduled evaluations and to complete all required tests and procedures in either English or Spanish.
- In the opinion of the PI, the participant must be considered likely to comply with the study protocol and to have a high probability of completing the study.
Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.